Abstract：Objective To explore the value of serum pepsinogen (PG)Ⅰ, PGⅠ/Ⅱ combined with tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199) and cancer antigen 125 (CA125) in the diagnosis of gastric cancer. Methods Eighty patients with gastric cancer diagnosed by pathological biopsy from People′s Hospital of Yangjiang City from January 2019 to December 2020 were selected as the gastric cancer group, 80 patients with benign gastric lesions diagnosed at the same time were selected as the benign lesion group, and 60 healthy experiencers were selected as the control group. The levels of PGⅠ, PGⅠ/Ⅱ, CEA, CEA, CA199, CA125 and the sensitivity, specificity and accuracy of single detection and combined detection were compared among the three groups. Results The PGⅠand PGⅠ/Ⅱ in the gastric cancer group were lower than those of the benign lesion group and the control group, and the differences were statistically significant (P＜0.05). The levels of CEA, CA199, and CA125 in the gastric cancer group were higher than those of the benign lesion group and the control group, and the differences were statistically significant (P＜0.05). In gastric cancer group, the sensitivity and accuracy of combined detection were higher than those of single detection, and the differences were statistically significant (P＜0.05). The specificity decreased but remained good.Conclusion The combine detection of PGⅠ, PGⅠ/Ⅱ, CEA, CA199, and CA125 has high sensitivity, accuracy and good specificity, which can improve the diagnostic efficiency of gastric cancer.
林荣军；陈振奋；杨丽萍；陈冬玲；黎杨杨. 血清胃蛋白酶原联合肿瘤标志物CEA、CA199、CA125在胃癌诊断中的价值研究[J]. 中国当代医药, 2021, 28(35): 184-186.
LIN Rong-jun CHEN Zhen-fen YANG Li-ping CHEN Dong-ling LI Yang-yang. Study on the value of serum pepsinogen combined with tumor markers CEA, CA199, CA125 in the diagnosis of gastric cancer. 中国当代医药, 2021, 28(35): 184-186.
京公网安备 11010502046607号